Platelet transfusion: A dose-response study

Blood

Volumn 92, Issue 4, 1998, Pages 1448-1453

  Norol, Françoise ^a   Bierling, Philippe ^b   Roudot Thoraval, Françoise ^b   Coeur, Françoise Ferrer Le ^b   Rieux, Claire ^b   Lavaux, Anne ^b   Kuentz, Mathieu ^b   Duedari, Najib ^b  

^a HENRI MONDOR HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD COMPATIBILITY; BLOOD DYSCRASIA; BODY WEIGHT; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SCHOOL CHILD; THROMBOCYTE COUNT; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOCYTOPHERESIS; TREATMENT OUTCOME;

EID: 0032529491     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1448     Document Type: Article

References (23)

1. Kretschmer V: Current trends in platelet transfusion - Transfusion practices in Europe. Infusionsther Transfusionsmed 23:5, 1996
2. Basser RL, Rasko JEJ, Clarke K, Cebon J, Green MD, Hussein S, AIT C, Menchaca D, Tomita D, Marty J, Fox RM, Begley CG: Thrombopoietic effects of pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) in patients with advanced cancer. Lancet 348:1279, 1996
3. The National Institutes of Health Consensus Conference: Platelet transfusion therapy. Transfus Med Rev 3:195, 1987
4. Murphy MF: Guidelines for platelet transfusion. JAMA 259:2453, 1988
5. Murphy MF, Waters AH: Clinical aspects of platelet transfusions. Blood Coagul Fibrinol 2:389, 1991
6. Slichter SJ: Platelet transfusions: A constantly evolving therapy. Thromb Haemost 66:178, 1991
7. Murphy MF, Brozovic B, Murphy W, Ouwehand W, Waters AH: The British Comittee for Standars in Haematology - Guildelines for platelet transfusions. Transfus Med 2:311, 1992
8. Slichter JS: Controversies in platelet transfusion therapy. Annu Rev Med 31:509, 1980
9. Baer MR, Bloomfield CD: Controversies in transfusion medicine. Prophylactic platelet transfusion therapy:pro. Transfusion 32:377, 1992
10. Rebulla P, Finazzi G, Marangoni F, Avvisati G, Gugliotta L, Tognoni G, Barbui T, Mandelli F, Sirchia G: The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. N Engl J Med 26:1870, 1997
11. Slichter SJ: Mechanisms and management of platelet refractoriness. The Emily Cooley memorial lecture. Arlington, YA, American Association of Blood Banks, 1990
12. Morrison FS: Platelet Transfusion: A brief review of pratical aspects. Vox Sang 2:656, 1966
13. Jones RJ, Lee KSK, Beschorner WE, Vogel VG, Brochow LB, Braine HG, Vogelsaung GB, Sensenbrenner LL, Santos WG, Sarai R: Veno-occlusive disease of the liver following bone marrow transplantation. Transplantation 44:778, 1987
14. Burakoff GJ, Defg HJ, Ferrara J, Atkinson K: Immunology, pathophysiology and treatment, in Graft Versus Host Disease. New York, NY, Dekker, 1990, p 311
15. Fuller TC, Phelan D, Gebel HM, Rodey GE: Antigenic specifity of antibody reactive in the antiglobulin-augmented lymphocytotocicity test. Transplantation 34:24, 1982
16. Norol F, Aubert C, Scotto F, Duedari N: Pheresis experience with the Dideco Vivacell flow separator. Transfusion 28:470, 1988
17. Freireich EJ: Transfusional therapy for cancer patients. Curr Probl Cancer 3:1, 1978
18. Roy AJ, Jaffe N, Djerassi I: Prophylactic platelet transfusions in children with acute leukemia: A dose response study. Transfusion 13:5, 1973
19. Andreu G: Transfusions plaquettaires dans les insuffisances médullaires. Transfus Clin Biol 1:27, 1995
20. Hanson SR, Slichter SJ: Platelet kinetics in patients with bone marrow hypoplasia: Evidence for a fixed platelet requirement. Blood 66:1105, 1985
21. Voak D, Cann R, Finney RD, Fraser ID, Mitchell R, Murphy MF, Napier JAP, Phillipps P, Rejman AJ, Waters AH, Wood IK: Guidelines for administration of blood products: Transfusion of infants and neonates. Transfus Med 4:63, 1994
22. Gharpure VS, Morris D, Lee EJ, Schiffer CA: Use of "Slit" platelet pheresis products for alloimmunized patients. Vox Sang 67:272, 1994
23. Kuter D, McCullough J, Romo J, DiPersio J, Peterson R, Armstrong S, Menchaca D, Tomita D, Goodnough LT: Treatment of platelet (PLT) donors with pegylated recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) increases circulating PLT counts (CTS) and PLT apheresis yields and increases platelet increments in recipients of PLT transfusions. Thirty-Ninth Annual Meeting of The American Society of Hematology, San Diego, CA, 1997 p 579a